These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17875478)

  • 1. Production of plasmid DNA for pharmaceutical use.
    Voss C
    Biotechnol Annu Rev; 2007; 13():201-22. PubMed ID: 17875478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scaleable processes for the manufacture of therapeutic quantities of plasmid DNA.
    Shamlou PA
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):207-18. PubMed ID: 12683955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA.
    Tolmachov OE
    Med Hypotheses; 2010 Apr; 74(4):702-4. PubMed ID: 19914006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy progress and prospects: magnetic nanoparticle-based gene delivery.
    Dobson J
    Gene Ther; 2006 Feb; 13(4):283-7. PubMed ID: 16462855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marker-free plasmids for gene therapeutic applications--lack of antibiotic resistance gene substantially improves the manufacturing process.
    Mairhofer J; Cserjan-Puschmann M; Striedner G; Nöbauer K; Razzazi-Fazeli E; Grabherr R
    J Biotechnol; 2010 Apr; 146(3):130-7. PubMed ID: 20138928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the heart with gene therapy-optimized gene delivery methods.
    Müller OJ; Katus HA; Bekeredjian R
    Cardiovasc Res; 2007 Feb; 73(3):453-62. PubMed ID: 17097076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Latest development in viral vectors for gene therapy.
    Lundstrom K
    Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of oligonucleotides for therapeutic applications.
    Fichou Y; Férec C
    Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Dressed-up" naked plasmids: emerging vectors for non-viral gene therapy.
    Gôrecki DC
    Discov Med; 2006 Oct; 6(35):191-7. PubMed ID: 17234141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal-free production of ccc-supercoiled plasmids for research and clinical applications.
    Schleef M; Schmidt T
    J Gene Med; 2004 Feb; 6 Suppl 1():S45-53. PubMed ID: 14978750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perspectives on plasmid-based gene therapy: challenges for the product and the process.
    Kelly WJ
    Biotechnol Appl Biochem; 2003 Jun; 37(Pt 3):219-23. PubMed ID: 12672266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodegradable polymers as non-viral carriers for plasmid DNA delivery.
    Luten J; van Nostrum CF; De Smedt SC; Hennink WE
    J Control Release; 2008 Mar; 126(2):97-110. PubMed ID: 18201788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.
    Karmali PP; Chaudhuri A
    Med Res Rev; 2007 Sep; 27(5):696-722. PubMed ID: 17022036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Towards non-viral gene therapy].
    Scherman D
    Bull Acad Natl Med; 2001; 185(9):1683-97. PubMed ID: 12146060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus-mediated gene delivery approaches for the treatment of CNS disorders.
    Terzi D; Zachariou V
    Biotechnol J; 2008 Dec; 3(12):1555-63. PubMed ID: 19072910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exhaustive in vivo labelling of plasmid DNA with BrdU for intracellular detection in non-viral transfection of mammalian cells.
    Jérôme V; Heider A; Schallon A; Freitag R
    Biotechnol J; 2009 Oct; 4(10):1479-87. PubMed ID: 19670251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-low sized cross-linked polyvinylpyrrolidone nanoparticles as non-viral vectors for in vivo gene delivery.
    Saxena A; Mozumdar S; Johri AK
    Biomaterials; 2006 Nov; 27(32):5596-602. PubMed ID: 16872672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.